W.L. Gore & Associates announced that it enrolled the first U.S. patient in a clinical trial for its Viafort vascular stent. Gore aims to evaluate Viafort for the treatment of symptomatic inferior vena cava (IVC) obstruction with or without iliofemoral obstruction. The prospective, non-randomized, multi-center, single-arm study … [Read more...] about Gore enrolls first U.S. patient in vascular stent trial
W.L. Gore & Associates
Gore voluntarily recalls some balloon catheters
W.L. Gore and Associates recently announced the voluntary product recall of its Molding and Occlusion Balloon (MOB) Catheters. The Newark, Delaware-based manufacturing company issued the warning due to complaints of leakage from the guidewire lumen and the y-hub during the preparation or use of the MOB catheters. The issue could result in … [Read more...] about Gore voluntarily recalls some balloon catheters
W. L. Gore debuts lower-profile endoprosthesis
W.L. Gore this week announced it has launched its lower profile, large diameter Gore ViaBahn Endoprosthesis. The device design reduces the delivery profile for larger 9-13 mm diameter stent grafts by up to 3 Fr to enable delivery through smaller sheaths. The smaller introducer sheaths result in a lower risk of vascular access complications and … [Read more...] about W. L. Gore debuts lower-profile endoprosthesis
W.L. Gore officials think they can spur insulin delivery system innovation
W.L. Gore announced this week that it is investing in PhysioLogic Devices, a startup developing an implantable intraperitoneal insulin delivery system. The size of the investment was not disclosed. But it was part of Gore's Micro-Equity Investment (MEI) program, which provides investments of up to $500,000. W.L. Gore officials think the … [Read more...] about W.L. Gore officials think they can spur insulin delivery system innovation
